April 23 is the first day for trading in the Mertiva share (ex Diamyd Medical) excluding redemption rights and entitlement to distribution in kind

This has been communicated in a previous press release, but the company wants to
make the market aware of this again to avoid any misunderstandings.
For more information, please contact:
info@mertiva.se
About Mertiva
Mertiva AB (former Diamyd Medical) primarily consists of holdings in liquid
assets and holdings in Protein Sciences Corporation and Mercodia AB.

Mertiva (former Diamyd Medical) shares are listed on Nasdaq OMX (segment Small
Cap) in Stockholm (ticker: DIAM B) and on OTCQX in the US (ticker: DMYDY)
administered by the Pink OTC Markets and the Bank of New York Mellon (PAL).

More information can be found at www.mertiva.se

This information is disclosed in accordance with the Swedish Securities Markets
Act, the Swedish Financial Instruments Trading Act, or the requirements stated
in the listing agreements.

Mertiva AB (publ)
Karlavägen 108, SE-115 26 Stockholm, Sweden.
E-mail: info@mertiva.com. Reg. no: 556530-1420